pharma · Alopecia areata · Multiple myeloma
First Biotech (Australia)
Pfizer Australia Pty Ltd
Pfizer Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Alopecia areata, Multiple myeloma, Heart failure, Acute Migraine (with or without aura), Transthyretin amyloidosi
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU
- Founded
- 2017
- Employees
- 2
- Programs
- 126
- Drugs
- 208
- Patents
- 0
C5091010
Phase 1 · other · severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
C5091010 for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a Phase 1 program (other) at Pfizer Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code C5091010
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Pfizer Australia Pty Ltd
- Phase
- Phase 1
- Modality
- other
- Indication
- severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Status
- active
- Trials
- 1